Sharps Technology, Inc. (STSS)
2.37
+0.07
(+3.04%)
USD |
NASDAQ |
Jan 16, 16:00
2.25
-0.12
(-5.06%)
Pre-Market: 08:35
Sharps Technology EPS Diluted (Quarterly): -4.327 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -105.33M |
| Revenue (Quarterly) | 2.289M |
| Total Expenses (Quarterly) | 107.62M |
| Enterprise Value | 20.62M |
| Gross Profit Margin (Quarterly) | 38.91% |
| Profit Margin (Quarterly) | -4.60K% |
| Earnings Yield | -26.38K% |
| Normalized Earnings Yield | -18551.98 |